DUBLIN–(BUSINESS WIRE)–The “Carpal Tunnel Syndrome – Global Clinical Trials Review, H2, 2021” report has been added to ResearchAndMarkets.com’s offering.
“Carpal Tunnel Syndrome – Global Clinical Trials Review, H2, 2021” provides an overview of Carpal Tunnel Syndrome clinical trials scenarios.
This report provides top line data relating to the clinical trials on Carpal Tunnel Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end point status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Scope
- the report provides a snapshot of the global clinical trials landscape
- the report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- the report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- the report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for non-accomplishment
- the report provides enrollment trends for the past five years
- the report provides latest news for the past three months
Clinical Trials Report Coverage
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Countries Contributing to Clinical Trials in Middle East and Africa
- Top Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by G7 Countries: Proportion of Carpal Tunnel Syndrome to Central Nervous System Clinical Trials
- Clinical Trials by Phase in G7 Countries
- Clinical Trials in G7 Countries by Trial Status
- Clinical Trials by E7 Countries: Proportion of Carpal Tunnel Syndrome to Central Nervous System Clinical Trials
- Clinical Trials by Phase in E7 Countries
- Clinical Trials in E7 Countries by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Clinical Trials by End Point Status
- Subjects Recruited Over a Period of Time
- Clinical Trials by Sponsor Type
- Prominent Sponsors
- Top Companies Participating in Carpal Tunnel Syndrome Therapeutics Clinical Trials
- Prominent Drugs
- Clinical Trial Profile Snapshots
Companies Mentioned
- Tri-Service General Hospital
- Endo International Plc
- Ono Pharmaceutical Co Ltd
- Sumitomo Chemical Co Ltd
- AbbVie Inc
- Alfasigma SpA
- Avadim Health Inc
- Bristol-Myers Squibb Co
- Charles River Laboratories International Inc
- Elsan SAS
For more information about this clinical trials report visit https://www.researchandmarkets.com/r/j2898x
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900